Global Animal Health Market Trends, Forecast Report 2025-2037
Animal Health Market size is poised to rise from USD 48.36 billion to USD 203.96 billion, witnessing a CAGR of more than 11.7% throughout the forecast period, between 2025 and 2037. In the year 2025, the industry size of animal health is evaluated at USD 52.93 billion.
The market growth is attributed to rising pet ownership and growing demand for animal health care products. For instance, pet ownership is expected to account for approximately 17.5 million households in 2022.
Animal health includes preserving and protecting animals from various diseases as well as providing required veterinarian treatments. It also entails regular animal monitoring in order to prevent spread of disease through the use of appropriate medications and diagnostic products. It ensures food safety and protects the public from animal-borne diseases.
The increasing count of government initiatives to support and spread more awareness about animal health is boosting the market growth. For instance, for monitoring good health of animals, the government of India launched National Animal Disease Control Program (NADCP) in 2019. This program has launched to monitor Foot and Mouth Disease and Brucellosis by vaccinating 100% of the cattle, buffalo, sheep, goat, and pig populations for FMD and 100% of the female cattle calves aged 4-8 months.
Animal Health Sector: Growth Drivers and Challenges
Growth Drivers
- Upsurge in Zoonotic Diseases - Zoonotic diseases, or zoonoses, are spurred by germs that transfer from animals to humans. These diseases are carried out by pathogenic micro-organisms such as bacteria, fungi, parasites, and viruses. These organisms cause a wide range of ailments in humans and animals, from minor ailments to severe illness and even death. Thus, zoonotic diseases are leading the growth of animal health market. According to the World Economic Forum, zoonotic diseases are expected to cause 60% of acknowledged communicable diseases and up to 75% of recently found or emerging infectious diseases.
- Escalating Number of Livestock - For instance, in Europe, there were around 143 million pigs, 74 million cattle, 62 million sheep, and 10 million goats as of December 2021.
- Growing Prevalence of Diabetes in Pets – It is observed in a research, the prevalence of diabetes in pets is on the rise, growing by almost 81% in dogs and 17% in cats over a ten-year span.
- Growing Threat of Canine Parvovirus-2 (CPV-2) – For instance, in adult and young dogs, CPV-2 induces 100% morbidity and a 12% and 90% risk of mortality, accordingly.
- Rise in Per Capita Income - As per the World Bank statistics, global annual per capita income increased by 4.8% in 2021 contrasted to 2019, while it only increased by 1.5% in that year.
Challenges
- Stringent Government Policies on Approval of Animal Drugs
- Price Hike in Animal Health Products
- Escalating Cost of Animal Testing
Animal Health Market Highlights Over 2023 - 2033
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
11.7% |
|
Base Year Market Size (2024) |
USD 48.36 billion |
|
Forecast Year Market Size (2037) |
USD 203.96 billion |
|
Regional Scope |
|
Animal Health Segmentation
Product (Pharmaceuticals, Medicinal Feed Additives, Diagnostics)
The pharmaceuticals segment is estimated to garner largest animal health market share by 2037, owing to noticeable count of companion animals ownerships, growing number of veterinary practitioners, and surge in various zoonotic diseases across the globe. For instance, it estimated that, foot and mouth disease (FMD) affects nearly 76% of the world's cattle, primarily in Africa, the Middle East, and Asia, as well as a small portion of South America.
Major Macro-Economic Indicators Impacting the Market Growth
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
Our in-depth analysis of the global market includes the following segments:
|
By Product |
|
|
By Animal Type |
|
|
By End-User |
|
|
By Distribution Channel |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportAnimal Health Industry - Regional Synopsis
The market in North America is expected to hold majority share by the end of 2037, impelled by increasing technological advancement, rise in research and development of more advanced therapeutics, growing number of pet adoption, and surge in zoonotic diseases in the region. It has been noted that each year in the United States, approximately 3.4 million animals get adopted.
Companies Dominating the Animal Health Landscape
- Zoetis Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Heska Corporation
- Merck & Co., Inc.
- Ceva Santé Animale
- Virbac S.A.
- Midmark Corporation
- Biogenesis Bago SA
- Boehringer Ingelheim International GmbH
- Phibro Animal Health Corporation
- VETOQUINOL SA
In the News
- Boehringer Ingelheim International GmbH introduced Fencovis, a new vaccine for preventing calf diarrhea caused by E. coli F5 and bovine rotavirus. The vaccine provides passive immunity through the colostrum of cows.
- Zoetis Inc. has acquired Basepaws, a privately held pet care genetics company that delivers pet owners with genetic tests, analytics, and early health risk assessments of pets.
Author Credits: Radhika Pawar
- Report ID: 1225
- Published Date: Jan 17, 2025
- Report Format: PDF, PPT
